Overview

The Effect of Topical Application of Tranexamic Acid in Total Hip Arthroplasty Through the Direct Anterior Approach

Status:
Completed
Trial end date:
2020-04-01
Target enrollment:
0
Participant gender:
All
Summary
The effects of topical application of 3g tranexamic acid for 2 hours prior to opening of the suction drain following a total hip replacement
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Universitaire Ziekenhuizen Leuven
Treatments:
Tranexamic Acid
Criteria
Inclusion Criteria:

- patients who will receive a unilateral total hip arthroplasty

Exclusion Criteria:

- coagulopathy

- allergy to tranexamic acid

- preoperative anemia (a hemoglobin value of < 11g/dL in females and < 12g/dL in males)

- fibrinolytic disorders

- a history of arterial or venous thromboembolic disease

- pregnancy

- breastfeeding

- major comorbidities